FDA · Enforcement

Ready Med: FDA Warning Letter 730317

FDA stated that Ready Med's website claims about compounded semaglutide and tirzepatide could imply equivalence with approved drugs and could obscure which entity compounded the products.

Agency warning legal stageJun 8, 2026 record dateUnited States jurisdiction

Open the primary-source record

Record status

Open public record

Agency: U.S. Food and Drug Administration
Action: Warning letter
Stage: Agency warning
Last verified: Jul 10, 2026

Source-backed timeline

Status history

Jun 8, 2026Warning letter issuedSource

Editorial boundary: Peptide Report summarizes the public source and preserves its procedural stage. This page does not convert an allegation, proposal, advisory discussion, or warning into a final legal conclusion.

Back to all Regulatory Watch records